
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $285.7M | -- | -- | $0.72 | -- |
07/31/2025 | Q2 | $275.2M | -- | -- | $0.62 | -- |
05/01/2025 | Q1 | $272.4M | $279.7M | $0.01 | $0.48 | -$0.47 |
02/20/2025 | Q4 | $267.7M | $278.7M | $0.13 | $0.70 | -$0.57 |
11/07/2024 | Q3 | $255.1M | $264.2M | -$0.06 | $0.58 | -$0.64 |
08/08/2024 | Q2 | $245.1M | $252.1M | -$0.17 | $0.44 | -$0.61 |
05/02/2024 | Q1 | $240.1M | $247M | -$0.10 | $0.39 | -$0.49 |
02/21/2024 | Q4 | $238.1M | $239.1M | -$0.17 | $0.49 | -$0.66 |
11/02/2023 | Q3 | $224.5M | $230.1M | -$0.28 | $0.44 | -$0.72 |
06/30/2023 | Q2 | $214.8M | $222.9M | -$0.30 | $0.40 | -$0.70 |
03/31/2023 | Q1 | -- | $218.4M | -$0.38 | -- | -- |
12/31/2022 | Q4 | -- | $208.3M | -$0.19 | -- | -- |
09/30/2022 | Q3 | -- | $198.3M | -$0.33 | -- | -- |
06/30/2022 | Q2 | -- | $189.4M | -$0.34 | -- | -- |
03/31/2022 | Q1 | -- | $182.8M | -$0.49 | -- | -- |
12/31/2021 | Q4 | -- | $173.6M | -$0.05 | -- | -- |
09/30/2021 | Q3 | -- | $154.3M | -$0.30 | -- | -- |
06/30/2021 | Q2 | -- | $143.8M | -$0.25 | -- | -- |
03/31/2021 | Q1 | -- | $137.9M | -$0.18 | -- | -- |
12/31/2020 | Q4 | -- | $127.9M | -$0.11 | -- | -- |
09/30/2020 | Q3 | -- | $112.1M | -$0.17 | -- | -- |
06/30/2020 | Q2 | -- | $99.8M | -$0.25 | -- | -- |
03/31/2020 | Q1 | -- | $95.1M | -$0.12 | -- | -- |
12/31/2019 | Q4 | -- | $92.3M | $0.01 | -- | -- |
09/30/2019 | Q3 | -- | $83.8M | -$0.03 | -- | -- |
06/30/2019 | Q2 | -- | $77.4M | -$0.03 | -- | -- |
03/31/2019 | Q1 | -- | $74.5M | -$0.03 | -- | -- |
12/31/2018 | Q4 | -- | $72.3M | $0.06 | -- | -- |
09/30/2018 | Q3 | -- | $65.3M | -$0.02 | -- | -- |
06/30/2018 | Q2 | -- | $61.1M | -$0.04 | -- | -- |
03/31/2018 | Q1 | -- | $58.9M | -$0.01 | -- | -- |
12/31/2017 | Q4 | -- | $55.4M | -$0.01 | -- | -- |
09/30/2017 | Q3 | -- | $50.1M | $0.02 | -- | -- |
06/30/2017 | Q2 | -- | $47.7M | -$0.07 | -- | -- |
03/31/2017 | Q1 | -- | $47M | -$0.10 | -- | -- |
12/31/2016 | Q4 | -- | $44.2M | $0.01 | -- | -- |
09/30/2016 | Q3 | -- | $41M | -$0.07 | -- | -- |
06/30/2016 | Q2 | -- | $38.9M | -$0.07 | -- | -- |
03/31/2016 | Q1 | -- | $38M | -$0.10 | -- | -- |
12/31/2015 | Q4 | -- | $36M | -$0.07 | -- | -- |
09/30/2015 | Q3 | -- | $32.3M | -$0.12 | -- | -- |
Five9 reported $279.7M worth of top line sales in its most recent quarter.
Five9 announced earnings per share of $0.01 which represents a miss of analyst forecast a $0.48 per share.
Five9 reported $153.7M that represents $1.72 per share over the last quarter.
Five9's earnings are forecast to grow from -$0.17 per share to $2.37 per share next year representing an increase of --.
Five9's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.